SEC Form 3 · accession 0001193125-26-370943
AN2 Therapeutics, Inc. · ANTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron C. Trenor III
Officer — Chief Medical Officer
Period of report
Aug 24, 2026
Accepted (ET)
Aug 27, 2026 · 2:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001880438
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.